Trial Profile
An integrated pharmacological and psychological approach to young people with comorbid depression and substance abuse
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Major depressive disorder; Substance-related disorders
- Focus Therapeutic Use
- 25 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
- 29 Aug 2011 Company added as reported by Australian New Zealand Clinical Trials Registry.
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12605000675628).